The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis. 2024

Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
Neurology Department, University of Medicine, Pharmacy, Science and Technology "George Emil Palade" Targu Mures, 540142 Targu Mures, Mures, Romania.

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative central nervous system (CNS) disorder, characterized by focal inflammation, demyelination, irreversible axonal loss and neurodegeneration. The proposed mechanism involves auto-reactive T lymphocytes crossing the blood-brain barrier (BBB), contributing to inflammation and demyelination. Pro-inflammatory Th1 and Th17 lymphocytes are pivotal in MS pathogenesis, highlighting an imbalanced interaction with regulatory T cells. Dysbiosis in the gut microbiota, characterized by microbial imbalance is implicated in systemic inflammation, yet its exact role in MS remains elusive. Short-chain fatty acids (SCFAs), including valerate, butyrate, propionate, and acetate, produced through dietary fiber fermentation by the gut microbiota, modulate inflammation and immune responses. Particularly, butyrate and propionate exhibit pronounced anti-inflammatory effects in both the gut and CNS. These SCFAs influence regulatory T lymphocyte expression and BBB permeability. This review discusses the potential therapeutic implications of SCFA in MS, highlighting their ability to modulate the gut-brain axis and restore immune balance.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D002087 Butyrates Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure. Butyrate,n-Butyrate,Butanoic Acids,Butyric Acids,Acids, Butanoic,Acids, Butyric,n Butyrate
D005232 Fatty Acids, Volatile Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans. Fatty Acids, Short-Chain,Short-Chain Fatty Acid,Volatile Fatty Acid,Acid, Short-Chain Fatty,Acid, Volatile Fatty,Fatty Acid, Short-Chain,Fatty Acid, Volatile,Fatty Acids, Short Chain,Short Chain Fatty Acid,Short-Chain Fatty Acids,Volatile Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
March 2019, Acta biochimica Polonica,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
June 2021, International journal of molecular sciences,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
March 2019, Acta neurologica Scandinavica,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
April 2024, Neuromolecular medicine,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
September 2022, Nutrients,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
March 2022, European journal of neurology,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
September 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
June 2023, Journal of immunology (Baltimore, Md. : 1950),
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
January 2023, Frontiers in pharmacology,
Laura Barcutean, and Smaranda Maier, and Mihai Burai-Patrascu, and Lenard Farczadi, and Rodica Balasa
January 2022, Nutrition (Burbank, Los Angeles County, Calif.),
Copied contents to your clipboard!